Dali Pharmaceutical Co. Ltd. announced earnings results for the half year ended June 30, 2020. For the half year, the company announced sales was CNY 103.855 million compared to CNY 160.894 million a year ago. Operating income was CNY 2.203 million compared to CNY 12.275 million a year ago. Net income was CNY 545,625.5 compared to CNY 12.233 million a year ago. Basic earnings per share from continuing operations was CNY 0.0025 compared to CNY 0.0557 a year ago.